Litcius/Paper detail

Efficacy of three benznidazole dosing strategies for adults living with chronic Chagas disease (MULTIBENZ): an international, randomised, double-blind, phase 2b trial

Pau Bosch‐Nicolau, Marisa Fernández, Elena Sulleiro, Juan Carlos Villar, José A. Pérez‐Molina, Rodrigo Corrêa‐Oliveira, Sergio Sosa‐Estáni, Adrián Sánchez‐Montalvá, María del Carmen Bangher, Otacílio C. Moreira, Fernando Salvador, Ariela Mota Ferreira, Silvana Maria Elói-Santos, Núria Serre‐Delcor, Juan Carlos Ramı́rez, Aroa Silgado, Igor Henrique Rodrigues Oliveira, Oihane Martín, María Luisa Aznar, Antônio Luiz Pinho Ribeiro, Paulo Emílio Clementino Almeida, Sandra Chamorro-Tojeiro, Juan Espinosa‐Pereiro, Alfredo Maurício Batista de Paula, Eliana Vàquiro-Herrera, Carmen Tur, Israel Molina

2024The Lancet Infectious Diseases42 citationsDOIOpen Access PDF

Topics & Concepts

BenznidazoleMedicineChagas diseaseInternal medicinePopulationDosingRandomized controlled trialClinical trialImmunologyTrypanosoma cruziWorld Wide WebComputer scienceParasite hostingEnvironmental healthTrypanosoma species research and implicationsResearch on Leishmaniasis StudiesLysosomal Storage Disorders Research